Results 151 to 160 of about 13,758 (226)

Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases-Should It Be Offered? [PDF]

Ann Surg Oncol
Foster JM, Nash GM, Möller MG.
europepmc   +1 more source

Are current scales adequate for assessing quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? [PDF]

World J Clin Cases
Demirli Atici S, Canda AE, Terzi MC.
europepmc   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Cancer With Peritoneal Carcinomatosis. [PDF]

In Vivo
Lolis ED, Kyziridis D, Kalakonas A, Tentes AA.   +3 more
europepmc   +1 more source

Multimodale Therapiekonzepte bei fortgeschrittenen abdominellen und retroperitonealen Tumorerkrankungen: Innovationen und ihr Stellenwert [PDF]

, 2017
Albertsmeier, Markus
core  

Short-Term Effects of Hyperthermic Intraperitoneal Chemotherapy on Patients Following Cytoreductive Surgery: Retrospective Analysis From a Tertiary Care Center in Saudi Arabia. [PDF]

Cureus
Alahmad S, Alelaiyan S, Helmi H, Alrozaini F, Alwabel W, Albaqami G, Abdujawad AW, Alzahrani N.   +7 more
europepmc   +1 more source

Hyperthermic intraperitoneal chemotherapy enhances survival outcomes in primary ovarian cancer following cytoreductive surgery: a systematic review and meta-analysis. [PDF]

Front Oncol
Sun Q, Hu K, Chen J, Chen Y, Xie Z, Guan Y, Ying Y.   +6 more
europepmc   +1 more source

Long-term outcomes of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and its relevant risk factors in China: a retrospective study. [PDF]

Front Surg
Gao S, Zhang X, Yu Z, Zhang J.
europepmc   +1 more source

Letter to "Risk factors affecting prognosis in pseudomyxoma peritonei patients after hyperthermic intraperitoneal chemotherapy and cytoreductive surgery". [PDF]

Int J Surg
Fan Q, Jia L.
europepmc   +1 more source